No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 48.860
- -0.130-0.27%
Close Apr 24 16:00 ET
- 48.840
- -0.020-0.04%
Post 19:59 ET
99.03BMarket Cap12.66P/E (TTM)
49.045High48.550Low16.06MVolume49.000Open48.990Pre Close783.60MTurnover0.79%Turnover Ratio12.66P/E (Static)2.03BShares66.25352wk High3.36P/B98.83BFloat Cap47.03352wk Low2.31Dividend TTM2.02BShs Float76.835Historical High4.73%Div YieldTTM1.01%Amplitude8.510Historical Low48.800Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 280184.0 Shares on Sell Side
Bristol-Myers Earnings Preview: Major Near-term Headwinds Invites Worries About Q1 Results
Express News | Bristol-Myers Discloses Preliminary $6.29 Gaap & Non-Gaap EPS Impact for 3 Months Ended March 31 Related to Acquired Iprd & Licensing Income - Website
Economic schedule for 25th (Thu) ★ Alphabet, Microsoft financial results
<177A><7338>4/25 (Thursday) First win, month age 16.4 “6 wins and 4 losses” (taking the Nikkei average for the past 10 years) [Domestic] ★ Bank of Japan Financial Policy Meeting (Day 1) □ Status of Weekly External and Internal Securities Sales Agreements, etc. (8:50) □ February Business Trend Index [Revised Value] (14:00) □ March Restaurant Sales (14:00) □ March Nationwide Department Store Sales (14:00) □ March Nationwide Department Store Sales (14:30) [Domestic Companies] ★ Cojin Bio: TSE G Listed Invast [TSE] listing Abolish ○T&K <46
Express News | NYSE Order Imbalance 235573.0 Shares on Buy Side
S&P 500 Stocks With Biggest Estimated EPS Declines for Q1
Comments
FDA PDUFA Update…
🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
10
1
Major acquisition announced YTD in 2024
A look at one of the major acquisition deals YTD…👇
$MRTX
Acquired By: Bristol-Myers Squibb$Bristol-Myers Squibb(BMY.US$
Date: Jan. 23, 2024
Price: $4.8B
$AbbVie(ABBV.US$$GlaxoSmithKline(GSK.US$
$MRTX
Acquired By: Bristol-Myers Squibb$Bristol-Myers Squibb(BMY.US$
Date: Jan. 23, 2024
Price: $4.8B
$AbbVie(ABBV.US$$GlaxoSmithKline(GSK.US$
4
1
Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:
$SPDR S&P Biotech ETF(XBI.US$
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
2
$Eledon Pharmaceuticals(ELDN.US$ 10%🟢
First-ever Transplant of Genetically Modified Kidney
⇒ Pig to a Human
⇒ Use of Tegoprubart (anti-CD40L antibody)
⇒ Immunosuppressive treatment
$Bristol-Myers Squibb(BMY.US$
⇒ First CAR T Cell Therapy approval in the EU
⇒ Abecma
First-ever Transplant of Genetically Modified Kidney ⇒ Pig to a Human
⇒ Use of Tegoprubart (anti-CD40L antibody)
⇒ Immunosuppressive treatment
$Bristol-Myers Squibb(BMY.US$
⇒ First CAR T Cell Therapy approval in the EU
⇒ Abecma
3
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Ginvest : Thank you for the timely info